Shenzhen Capital Group Leads in Life Sciences Instrument Platform
08 Oct 2026
US$ 20.00
Shenzhen Capital Group has led the over Rmb50 m (US$7.5 m) pre-series A funding round of Optoseeker Biotechnology ......
Related Publications
Elevar Equity has led a US$9 m series B funding round of byteXL, an edtech learning platform focused on engineering...
BlackSoil Capital, an alternative credit platform, has provided 1.1 bn rupees (US$11.4 m) to Regency Healthcare Pvt Ltd...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.